LISA与INSRUE两种给药方式对极低体质量儿呼吸窘迫综合征应用的效果评价

付利珍; 刘真真; 张先红

doi:10.13406/j.cnki.cyxb.002824

您当前的位置：

首页 >

文章列表页 >

LISA与INSRUE两种给药方式对极低体质量儿呼吸窘迫综合征应用的效果评价

临床研究 | 更新时间：2022-06-24

- LISA与INSRUE两种给药方式对极低体质量儿呼吸窘迫综合征应用的效果评价
- Effect evaluation of less invasive surfactant administration and intubation surfactant exudation on respiratory distress syndrome in infants with very low birth weight
- 重庆医科大学学报 2022年47卷第5期页码：590-595
- 作者机构：
  
  重庆医科大学附属儿童医院新生儿诊治中心、国家儿童健康与疾病临床医学研究中心、儿童发育疾病研究教育部重点实验室、儿科学重庆市重点实验室，重庆　400014
- 作者简介：
  
  付利珍，Email：1050932890@qq.com，研究方向：新生儿临床护理。
  刘真真，Email：ioio_5566@126.com。
- 基金信息：
  
  2019年重庆医科大学附属儿童医院医疗新技术资助项目(〔2019〕285)
- DOI：10.13406/j.cnki.cyxb.002824
  中图分类号： R47
- 纸质出版日期：2022-05-28，
  
  收稿日期：2020-11-28，
扫描看全文
付利珍, 刘真真, 张先红. LISA与INSRUE两种给药方式对极低体质量儿呼吸窘迫综合征应用的效果评价[J]. 重庆医科大学学报, 2022,47(5):590-595.

Lizhen Fu, Zhenzhen Liu, Xianhong Zhang. Effect evaluation of less invasive surfactant administration and intubation surfactant exudation on respiratory distress syndrome in infants with very low birth weight[J]. Journal of Shanxi Agricultural Sciences, 2022,47(5):590-595.
付利珍, 刘真真, 张先红. LISA与INSRUE两种给药方式对极低体质量儿呼吸窘迫综合征应用的效果评价[J]. 重庆医科大学学报, 2022,47(5):590-595. DOI： 10.13406/j.cnki.cyxb.002824.

Lizhen Fu, Zhenzhen Liu, Xianhong Zhang. Effect evaluation of less invasive surfactant administration and intubation surfactant exudation on respiratory distress syndrome in infants with very low birth weight[J]. Journal of Shanxi Agricultural Sciences, 2022,47(5):590-595. DOI： 10.13406/j.cnki.cyxb.002824.

摘要

目的：

探讨细管（less invasive surfactant administration，LISA）与气管插管（intubation surfactant exudation，INSURE）2种给药方式注入肺表面活性物质（pulmonary surfactant，PS）治疗极低体质量儿呼吸窘迫综合征的效果评价。

方法：

选取2018年2月至2020年3月重庆医科大学附属儿童医院新生儿重症监护治疗病房（neonatal intensive care unit，NICU）收治的极低体质量儿呼吸窘迫综合征110例为研究对象，根据住院号尾号单双号分为对照组和观察组。其中对照组56例采取INSURE技术，观察组54例采取LISA技术。回顾性分析2组患儿插管一次性成功率、药液反流、PS再次使用率、72 h内机械通气率、机械通气时间、持续气道正压通气（continuous positive airway pressure，CPAP）使用时间、用氧时间、住院时间及住院费用等的差异。

结果：

在技术操作中，观察组插管一次性成功率高于对照组［98.15%（53/54）vs.85.71%（48/56），

=0.042］。在治疗过程中，观察组平均吸氧浓度（fraction of inspiration O

，FiO

）、心动过缓发生率、72 h内重新气管插管率低于对照组，差异均有统计学意义（

0.05）。机械通气使用率对照组高于观察组［30.36%（17/56）vs.12.96%（7/54），

=0.027］。平均住院费用对照组［（99 720.23±37 356.95）元］高于观察组［（85 630.83±34 110.20）元］，差异有统计学意义（

=0.041）。

结论：

气管内给予PS治疗极低体质量儿呼吸窘迫综合征，LISA技术优于INSRUE技术。

Abstract

Objective

To discuss the effect of less invasive surfactant administration (LISA) and intubation surfactant exudation (INSURE) to inject pulmonary surfactant (PS) on respiratory distress syndrome in infants with very low birth weight.

Methods

A total of 110 cases of very low birth weight infants with respiratory distress syndrome admitted to NICU (neonatal intensive care unit) of Children's Hospital of Chongqing Medical University from February 2018 to March 2020 were selected as the research objects

and they were divided into control group and observation group according to the single and double numbers of hospitalization number. Among them

56 cases in control group applied INSURE technique

and 54 cases in observation group applied LISA technique. The differences of one-time success of intubation

medication reflux

PS medication reuse rate

72 h mechanical ventilation rate

mechanical ventilation time

continuous positive airway pressure (CPAP) duration

oxygen time

hospitalization time and hospitalization expenses between the two groups were analyzed retrospectively.

Results

In this technique operation

one-time success rate of intubation in the observation group was higher than that in the control group［98.15% (53/54) vs.85.71% (48/56)

=0.042］. In the course of treatment

the average of fraction of inspiration O

(FiO

)

incidence of bradycardia

and rate of re-tracheal intubation within 72 hours in observation group were lower than those in control group

with significant differences (

0.05) . The utilization rate of mechanical ventilation in control group was higher than that in observation group ［30.36% (17/56) vs.12.96% (7/54)

=0.027］. The average hospitalization expenses in control group［ (99 720.23±37 356.95) yuan］were higher than those in observation group［ (85 630.83±34 110.20) yuan］

with significant differences (

=0.041) .

Conclusion

The LISA technique is superior to INSURE technique in the treatment of respiratory distress syndrome in very low weight infants.

关键词

极低体质量儿呼吸窘迫综合征细管气管插管

Keywords

infant with very low birth weightrespiratory distress syndromeless invasive surfactant administrationintubation surfactant exudation

references

Sweet DG, Carnielli V, Greisen G, et al. European consensus guidelines on the management of respiratory distress syndrome-2016 update[J]. Neonatology, 2017, 111(2): 107-125.

Lagercrantz H. Does CPAP work when it really matters?[J]. Acta Paediatr, 2007, 96(4): 481.

冯明华, 陈志君, 杨冰岩. LISA技术与INSURE技术分别联合NCPAP治疗新生儿呼吸窘迫综合征的效果比较[J]. 中国医学创新, 2019, 16(6): 54-57.

Feng MH, Chen ZJ, Yang BY. Comparison of efficacy between LISA technique and INSURE technique combined with NCPAP in treatment of neonatal respiratory distress syndrome[J]. Med Innov China, 2019, 16(6): 54-57.

Dunn MS, Kaempf J, de Klerk A, et al. Randomized trial comparing 3 approaches to the initial respiratory management of preterm neonates[J]. Pediatrics, 2011, 128(5): e1069-e1076.

Sandri F, Plavka R, Ancora G, et al. Prophylactic or early selective surfactant combined with nCPAP in very preterm infants[J]. Pediatrics, 2010, 125(6): e1402-e1409.

Cummings JJ, Polin RA. Noninvasive respiratory support[J]. Pediatrics, 2016, 137(1): 1-11.

Polin RA, Carlo WA, Newborn COFA, et al. Surfactant replacement therapy for preterm and term neonates with respiratory distress[J]. Pediatrics, 2014, 133(1): 156-163.

邵肖梅, 叶鸿瑁, 丘小汕. 实用新生儿学[M]. 4版. 北京: 人民卫生出版社, 2011.

Shao XM, Ye HM, Qiu XS. Practice of neonatology[M]. 4th ed. Beijing: People's Medical Publishing House, 2011.

王晓东, 周晓光. 肺表面活性物质替代疗法的护理[J]. 中华护理杂志, 2002, 37(7): 501-503.

Wang XD, Zhou XG. Nursing care of pulmonary surfactant replacement therapy[J]. Chin J Nurs, 2002, 37(7): 501-503.

赵宏, 王昌燕, 裴怀腾. LISA技术在新生儿呼吸窘迫综合征治疗中的应用价值[J]. 海南医学, 2019, 30(20): 2671-2673.

Zhao H, Wang CY, Pei HT. Application value of LISA in the treatment of neonatal respiratory distress syndrome[J]. Hainan Med J, 2019, 30(20): 2671-2673.

Yang G, Hei MY, Xue ZM, et al. Effects of less invasive surfactant administration (LISA)via a gastric tube on the treatment of respiratory distress syndrome in premature infants aged 32 to 36 weeks[J]. Medicine, 2020, 99(9): e19216.

Dani C, Corsini I, Bertini G, et al. The INSURE method in preterm infants of less than 30 weeks' gestation[J]. J Matern Fetal Neonatal Med, 2010, 23(9): 1024-1029.

Sweet DG, Carnielli V, Greisen G, et al. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants-2010 update[J]. Neonatology, 2010, 97(4): 402-417.

Sweet DG, Carnielli V, Greisen G, et al. European consensus guidelines on the management of respiratory distress syndrome-2019 update[J]. Neonatology, 2019, 115(4): 432-450.

Wyckoff MH, Aziz K, Escobedo MB, et al. Part 13: neonatal resuscitation: 2015 American heart association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care[J]. Circulation, 2015, 132(18 Suppl 2): S543-S560.

Lista G, Bresesti I, Fabbri L. Is less invasive surfactant administration necessary or only helpful or just a fashion?[J]. Am J Perinatol, 2018, 35(6): 530-533.

Li XF, Cheng TT, Guan RL, et al. Effects of different surfactant administrations on cerebral autoregulation in preterm infants with respiratory distress syndrome[J]. J Huazhong Univ Sci Technolog Med Sci, 2016, 36(6): 801-805.

钱文亚, 谢晓恬. 外源性肺表面活性物质治疗新生儿呼吸窘迫综合征研究进展[J]. 临床儿科杂志, 2018, 36(6): 476-479.

Qian WY, Xie XT. Research progress of exogenous pulmonary surfactant in the treatment of neonatal respiratory distress syndrome[J]. J Clin Pediatr, 2018, 36(6): 476-479.

祝正环. INSURE技术治疗早产儿呼吸窘迫综合征临床观察及安全性分析[J]. 中外医学研究, 2019, 17(1): 125-126.

Zhu ZH. Clinical observation and safety analysis of treating premature infant respiratory distress syndrome with INSURE technology[J]. Chin Foreign Med Res, 2019, 17(1): 125-126.

薛辛东, 富建华. “新生儿机械通气常规”解读[J]. 中华儿科杂志, 2015, 53(5): 331-333.

Xue XD, Fu JH. Interpretation of“routine mechanical ventilation of neonates”[J]. Chin J Pediatr, 2015, 53(5): 331-333.

刘云, 李丽, 梁文英, 等. 不同种类肺表面活性物质治疗新生儿呼吸窘迫综合征的疗效比较[J]. 中国当代儿科杂志, 2012, 14(4): 253-255.

Liu Y, Li L, Liang WY, et al. Comparisons of efficacy of different pulmonary surfactants for the treatment of neonatal respiratory distress syndrome[J]. Chin J Contemp Pediatr, 2012, 14(4): 253-255.

Hermansen CL, Mahajan A. Newborn respiratory distress[J]. Am Fam Physician, 2015, 92(11): 994-1002.

江云, 李健, 黎瑞春. 改良INSURE技术治疗早产儿呼吸窘迫综合征的效果观察[J]. 中国医学创新, 2020, 17(1): 129-132.

Jiang Y, Li J, Li RC. Therapeutic effect of modified INSURE technique in the treatment of respiratory distress syndrome in premature infants[J]. Med Innov China, 2020, 17(1): 129-132.

卢维城, 魏海波, 陈有平. 经胃管微创注入肺表面活性物质在新生儿呼吸窘迫综合征中的应用[J]. 广东医学, 2016, 37(21): 3233-3235.

Lu WC, Wei HB, Chen YP. Minimally invasive injection of pulmonary surfactant through gastric tube in neonates with respiratory distress syndrome[J]. Guangdong Med J, 2016, 37(21): 3233-3235.

雷媛. LISA技术与INSURE技术治疗NRDS的疗效对比研究[D]. 延安: 延安大学, 2019.

Lei Y. Comparative study on the efficacy of LISA and INSURE in the treatment of NRDS[D]. Yan'an: Yan'an University, 2019.

Gupta BK, Saha AK, Mukherjee S, et al. Minimally invasive surfactant therapy versus InSurE in preterm neonates of 28 to 34 weeks with respiratorydistresssyndromeonnon-invasivepositivepressure ventilation-a randomized controlled trial[J]. Eur J Pediatr, 2020, 179(8): 1287-1293.

Jomeh R, Boskabadi H, Maamouri G, et al. Comparative study of the effect of the administration of surfactant through a thin endotracheal catheter into Trachea during spontaneous breathing with intubation (intubation-surfactant-extubation method)[J]. J Clin Neonatol, 2019, 8(4): 227.

李琴, 汤文决. 82例极低出生体重儿日均住院费用调查分析[J]. 护理实践与研究, 2013, 10(1): 151-152.

Li Q, Tang WJ. Investigation analysis of very low birth weight infants on the daily average hospitalization[J]. Nurs Pract Res, 2013, 10(1): 151-152.

吴繁, 冯周善, 崔其亮, 等. 广东省26家三甲医院新生儿科超未成熟儿与超低出生体重儿的住院费用分析[J]. 实用医学杂志, 2020, 36(1): 108-114.

Wu F, Feng ZS, Cui QL, et al. Costs of hospitalization for extremely preterm and extremely low birth weight infants discharged from neonatology department of 26 tertiary hospitals in Guangdong Province[J]. J Pract Med, 2020, 36(1): 108-114.

王华, 侯东敏, 赵欣, 等. 78例极低出生体重儿住院费用调查及影响因素分析[J]. 中国病案, 2016, 17(8): 56-59.

Wang H, Hou DM, Zhao X, et al. Investigation on the hospitalization expenses of 78 cases of very low birth weight infants and relevant influencing factors[J]. Chin Med Rec, 2016, 17(8): 56-59.

刘艳红, 赵先锋, 梁桂娟, 等. LISA技术治疗早产儿呼吸窘迫综合征临床观察[J]. 儿科药学杂志, 2018, 24(5): 21-24.

Liu YH, Zhao XF, Liang GJ, et al. Less invasive surfactant administration technology in treating preterm infants with respiratory distress syndrome[J]. J Pediatr Pharm, 2018, 24(5): 21-24.

Herting E, Härtel C, Göpel W. Less invasive surfactant administration (LISA): chances and limitations[J]. Arch Dis Child Fetal Neonatal Ed, 2019, 104(6): F655-F659.

Buyuktiryaki M, Alarcon-Martinez T, Simsek GK, et al. Five-year single center experience on surfactant treatment in preterm infants with respiratory distress syndrome: LISA vs INSURE[J]. Early Hum Dev, 2019, 135: 32-36.

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

足月儿与早产儿呼吸窘迫综合征临床对比